Clinical utility of plasma Aβ42/40 ratio by LC-MS/MS in Alzheimer’s disease assessment
IntroductionPlasma Aβ42/40 ratio can help predict amyloid PET status, but its clinical utility in Alzheimer’s disease (AD) assessment is unclear.MethodsAβ42/40 ratio was measured by LC-MS/MS for 250 specimens with associated amyloid PET imaging, diagnosis, and demographic data, and for 6,192 consecu...
Main Authors: | Darren M. Weber, Steven W. Taylor, Robert J. Lagier, Jueun C. Kim, Scott M. Goldman, Nigel J. Clarke, David E. Vaillancourt, Ranjan Duara, Karen N. McFarland, Wei-en Wang, Todd E. Golde, Michael K. Racke |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-03-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2024.1364658/full |
Similar Items
-
INTEGRATED LC-MS/MS SYSTEM FOR PLANT METABOLOMICS
by: Yuji Sawada, et al.
Published: (2013-01-01) -
Integrated LC-MS/MS system for plant metabolomics
by: Yuji Sawada, et al.
Published: (2013-01-01) -
Determination of 355 Pesticides in Lemon and Lemon Juice by LC-MS/MS and GC-MS/MS
by: Sule Aslantas, et al.
Published: (2023-04-01) -
Largazole Pharmacokinetics in Rats by LC-MS/MS
by: Mingming Yu, et al.
Published: (2014-03-01) -
Comparison of Flow Injection-MS/MS and LC-MS/MS for the Determination of Ochratoxin A
by: Kai Zhang
Published: (2021-08-01)